amifampridine has been researched along with Encephalopathy, Toxic in 1 studies
Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harris, TL | 1 |
Lowery, CA | 1 |
Hixon, MS | 1 |
Janda, KD | 1 |
1 other study available for amifampridine and Encephalopathy, Toxic
Article | Year |
---|---|
A platform stratifying a sequestering agent and a pharmacological antagonist as a means to negate botulinum neurotoxicity.
Topics: 4-Aminopyridine; Amifampridine; Animals; Botulinum Antitoxin; Botulinum Toxins; Drug Therapy, Combin | 2014 |